| 英文别名： |
Deferoxamine mesylate;Deferoxamine mesylate salt;Deferoxamine (mesylate);EHNA;Deferoxamine Methanesulfonate;Desferrioxamine B mesylate;DFOM;DFOM,Deferoxamine methanesulfonate salt,Desferrioxamine mesylate salt;Deferoxamine methanesulfonate salt;Desferrioxamine mesylate salt;desferal;Prestwick_988;desferalmesylate;deferoxaminemesilate;deferoxaminebmesylate;desferalmethanesulfonate;monomethanesulfonate(sa;desferrioxaminebmesylate;DEFEROXAMINE MESYLATE;MFCD00058605;Deferoxamine mesilate;Propionohydroxamic acid, N-(5-(3-((5-aminopentyl)hydroxycarbamoyl)propionamido)pentyl)-3-((5-(N-hydroxyacetamido)pentyl)carbamoyl)-, monomethanesulfonate (salt);Q27114315;SCHEMBL119982;DEFEROXAMINE METHANESULFONATE [MI];DEFEROXAMINE MESYLATE [ORANGE BOOK];HMS500E04;N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-1,4-dioxobutyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide; methanesulfonic acid;DEFEROXAMINE MESYLATE [USP-RS];CAS-138-14-7;DEFEROXAMINE MESYLATE [VANDF];V9TKO7EO6K;Desferrioxamine B mesylate;DFOM;DEFEROXAMINE MESILATE [EP MONOGRAPH];DEFEROXAMINE MESILATE [WHO-IP];DESFERRIOXAMINE MESYLATE [WHO-IP];Deferoxamine mesylate [USAN];SR-01000695424;Deferoxamine Mesylate - CAS 138-14-7;HMS1570A12;IDDIJAWJANBQLJ-UHFFFAOYSA-N;s5742;Desferal mesylate;SR-01000695424-3;Ba 33122;Deferoxamine for system suitability, European Pharmacopoeia (EP) Reference Standard;Desferal (TN);HMS3714A12;NS00079182;FT-0603121;AC-36517;AKOS026750165;NSC756718;BCP31290;NCGC00017021-01;Deferoxamine mesylate [USAN:USP];DEFEROXAMINE MESYLATE [USP MONOGRAPH];deferoxaminemesylate;Butanediamide, N'-(5-((4-((5-(acetylhydroxyamino)pentyl)amino)-1,4-dioxobutyl)hydroxyamino)pentyl)-N-(5-aminopentyl)-N-hydroxy-, monomethanesulfonate;Deferoxamine mesylate (USP);Deferoxamini mesilas;Pharmakon1600-01500224;Desferal;SR-01000695424-4;N'-{5-[acetyl(hydroxy)amino]pentyl}-N-[5-({4-[(5-aminopentyl)(hydroxy)amino]-4-oxobutanoyl}amino)pentyl]-N-hydroxysuccinamide methanesulfonate (salt);SPECTRUM1500224;SMR000058548;Deferoxamine mesylate salt, European Pharmacopoeia (EP) Reference Standard;NCGC00178802-06;SY066727;NSC 756718;N-(5-(3-((5-Aminopentyl)hydroxycarbamoyl)propionamido)pentyl)-3-((5-(N-hydroxyacetamido)pentyl)carbamoyl)propionohydroxamic acid monomethanesulfonate (salt);N1-(5-aminopentyl)-N1-hydroxy-N4-(5-(N-hydroxy-4-(5-(N-hydroxyacetamido)pentylamino)-4-oxobutanamido)pentyl)succinamide methanesulfonate;DEFEROXAMINE MESILATE [JAN];Tox21_110741;D01186;138-14-7;HMS1920C16;HMS2097A12;MLS000028713;CHEMBL1234;N4-[5-[[4-5-(Acetylhydroxyamino)pentyl]-1,4-dioxobutyl]hydroxyaminopentyl-N1-(5-aminopentyl)-N1-hydroxybutanediamide methanesulfonate;N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide;methanesulfonic acid;Deferoxamine mesylate, United States Pharmacopeia (USP) Reference Standard;Desferioxamine ... |
沪公网安备31011402010658号 
